Related Experiment Video
Updated: Jun 15, 2025

06:42
Author Spotlight: Understanding Disease Mechanisms Through Real-Time Analysis of T-Cell Migration
Published on: May 24, 2024
1.3K
T cell trafficking in human chronic inflammatory diseases
Anna Giovenzana1, Valentina Codazzi1, Michele Pandolfo1
1Diabetes Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Iscience
|August 22, 2024
Summary
T cells that recirculate between tissues and blood are key to chronic inflammation. Understanding this T cell trafficking offers new therapeutic targets for diseases like multiple sclerosis and inflammatory bowel disease.
Area of Science:
- Immunology
- Cell Biology
- Pathophysiology
Background:
- Circulating T cells migrate to inflamed tissues, driving chronic inflammatory conditions.
- Tissue-resident T cells can regain migratory capacity, becoming "recirculating T cells."
Purpose of the Study:
- To review recent advancements in T cell trafficking and recirculation biology.
- To explore the role of T cell migration in inflammatory and metabolic diseases.
- To discuss therapeutic strategies and technologies for studying T cell recirculation.
Main Methods:
- Literature review of recent research on T cell biology and trafficking.
- Analysis of T cell migration in multiple sclerosis, inflammatory bowel diseases, and metabolic disorders.
- Discussion of current therapeutic approaches and technological advancements.
Main Results:
- T cell infiltration is pivotal in multiple sclerosis and inflammatory bowel diseases.
- The role of T cell migration in metabolic disorders is an emerging area of research.
- Modulating T cell circulation presents a novel therapeutic avenue.
Conclusions:
- Investigating T cell trafficking is crucial for understanding chronic inflammatory diseases.
- Targeting T cell recirculation offers potential for new therapeutic interventions.
- Advanced technologies are enabling deeper insights into human T cell recirculation.
Related Concept Videos
T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963
T Cell Activation and Clonal Selection
692
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
692
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
Cell-mediated Immune Responses
67.9K
Overview
67.9K

